MiraVista Diagnostics is an Industry Leading Mycology Reference Laboratory
Clinical Laboratory Testing for Serious Fungal Infections
The company was founded in 2002 by the renowned infectious disease scientist, Dr. Lawrence Joseph Wheat, whose groundbreaking research contributions resulted in the development of the first histoplasmosis antigen test in 1986. Today, MiraVista Diagnostics serves the medical and healthcare sectors in the U.S. and Canada processing over 100,000 tests per year for fungal infections. This includes antigen and antibody detection tests for coccidioides (valley fever fungus), aspergillus, histoplasmosis capsulatum, Blastomyces dermatitidis and cryptococcus.
MiraVista Diagnostics offers same-day testing, prompt response, fast shipping and direct access to the laboratory’s team of experienced infectious disease specialists that has collectively published more than 1,000 scientific research articles. Clients include large medical research hospitals, healthcare systems and universities as well as large reference labs. Contact us to discuss a fungal infection case, set up a corporate account for high volume testing or order from among MiraVista Diagnostics’ menu of diagnostic screening tests for fungal diseases.
American College of Chest Physicians (CHEST)
October 19-22, 2025 American College of Chest Physicians Chicago, IL MiraVista Diagnostics will be at this event. Booth # 1044 This event will bring you the most up-to-date education in clinical pulmonary, critical care, and sleep medicine with world-class speakers,…
READ MORE →
Infectious Disease Society of America (IDWeek)
October 19-22, 2025 Infectious Disease Society of America Atlanta, GA MiraVista Diagnostics will be at this event. Booth # 629 Surround yourself with the ID experts who are advancing the field of Infectious Disease. Choose scientific programming that’s tailored to…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines, research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
American College of Chest Physicians Boston, MA October 6-9, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT This event will bring you the most up-to-date education in clinical pulmonary, critical care,…
READ MORE →
ID WEEK Los Angeles, CA October 16-20, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
